The journal retracts the article titled “Molecular Investigation of DKK3 in Cerebral Ischemic/Reperfusion Injury” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of a figure presented in this publication [1].
In accordance with the journal’s standard procedures, the Editorial Office and Editorial Board conducted an investigation that identified indications of inappropriate editing in Figure 5. Although the authors cooperated with the investigation, the explanations and supporting materials provided were not deemed sufficient by the Editorial Board to resolve the identified concerns. As a consequence, the Editorial Board has lost confidence in the reliability of the reported findings and has decided to retract this publication in accordance with MDPI’s retraction policy.
This retraction was approved by the Editor-in-Chief of the Biomedicines journal.
The authors have been informed of this retraction but did not provide a comment on this decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Caffo M., Fusco R., Siracusa R., Caruso G., Barresi V., Di Paola R., Cuzzocrea S., Germanò A.F., Cardali S.M. RETRACTED: Molecular Investigation of DKK3 in Cerebral Ischemic/Reperfusion Injury. Biomedicines. 2023;11:815. doi: 10.3390/biomedicines11030815. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]